Incidence and risk factors for liver enzyme elevation during highly active antiretroviral therapy in HIV-HCV co-infected patients: results from the Italian EPOKA-MASTER Cohort.
Torti C, Lapadula G, Casari S, Puoti M, Nelson M, Quiros-Roldan E, Bella D, Pastore G, Ladisa N, Minoli L, Sotgiu G, Mazzotta F, Lo Caputo S, Di Perri G, Filice G, Tinelli C, Carosi G; EPOKA-MASTER Study Group.
Torti C, et al. Among authors: filice g.
BMC Infect Dis. 2005 Jul 14;5:58. doi: 10.1186/1471-2334-5-58.
BMC Infect Dis. 2005.
PMID: 16018804
Free PMC article.